Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8504 |
High Similarity |
NPD9493 |
Approved |
0.8239 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.806 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7961 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7955 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7939 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7883 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7874 |
Intermediate Similarity |
NPD74 |
Approved |
0.7857 |
Intermediate Similarity |
NPD411 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7815 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7795 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7795 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7795 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7793 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7712 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7697 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7603 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7603 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7603 |
Intermediate Similarity |
NPD5408 |
Approved |
0.76 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7591 |
Intermediate Similarity |
NPD1201 |
Approved |
0.758 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1164 |
Approved |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7481 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.748 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7462 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7452 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5403 |
Approved |
0.744 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7431 |
Intermediate Similarity |
NPD520 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7391 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD943 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7358 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD5401 |
Approved |
0.732 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7212 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD5647 |
Approved |
0.72 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7171 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7163 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1512 |
Approved |
0.716 |
Intermediate Similarity |
NPD8312 |
Approved |
0.716 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7154 |
Intermediate Similarity |
NPD164 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7042 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2651 |
Approved |
0.702 |
Intermediate Similarity |
NPD6099 |
Approved |
0.702 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD920 |
Approved |
0.7 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD9268 |
Approved |
0.6993 |
Remote Similarity |
NPD1243 |
Approved |
0.6993 |
Remote Similarity |
NPD2800 |
Approved |
0.6982 |
Remote Similarity |
NPD5953 |
Discontinued |
0.698 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6974 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5494 |
Approved |
0.695 |
Remote Similarity |
NPD17 |
Approved |
0.6947 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD1876 |
Approved |
0.6939 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6934 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6651 |
Approved |
0.6932 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6912 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD2438 |
Suspended |
0.6908 |
Remote Similarity |
NPD4477 |
Approved |
0.6908 |
Remote Similarity |
NPD4476 |
Approved |
0.6905 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6905 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6893 |
Remote Similarity |
NPD6534 |
Approved |
0.6893 |
Remote Similarity |
NPD6535 |
Approved |
0.6892 |
Remote Similarity |
NPD6798 |
Discontinued |
0.689 |
Remote Similarity |
NPD919 |
Approved |
0.6884 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4661 |
Approved |
0.6879 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4662 |
Approved |
0.6875 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6872
|
Remote Similarity |
NPD4668 |
Phase 2 |